Prof Ian Barr
Honorary Professorial Fellow
Department of Microbiology and Immunology
388 Scholarly works
4 Projects
HIGHLIGHTS
2026
Journal article
Influenza
DOI: 10.1038/s41572-026-00727-52026
Journal article
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity
DOI: 10.1038/s41467-026-73988-z2026
Journal article
Multiomic analysis identifies glutaminolysis-dependent metabolic enhancement of immune memory utilised for vaccine development
DOI: 10.1038/s41467-026-74866-42026
Journal article
COVID-19 disruption and rebound of respiratory syncytial virus hospital burden in Australia: A national interrupted time-series analysis
DOI: 10.1016/j.jiph.2026.1033372024
Research grants (international)
(CRA With Melbourne Health and Aus Bio) Development of a Novel Long Acting Pan-Influenza Antiviral Drug
2020
Research Grant
“Immunity Passport” to COVID19
2019
Research Grant
Understanding Heterogeneity in Influenza Vaccine Responses and the Effects of Prior Exposures Through Infection and Vaccination
RECENT SCHOLARLY WORKS
2026
Journal article
Near real-time data on the human neutralizing antibody landscape to influenza virus in summer of 2026 shows antigenic advance of H3N2 subclade K region D mutants and H1N1 D.3.1.1 Sa mutants.
DOI: 10.64898/2026.09.15.7518552026
Journal article
A Cluster of Influenza A(H3N2) Viruses in 2024 From Tasmania, Australia, With Reduced Susceptibility to Baloxavir.
DOI: 10.1111/irv.703122026
Journal article
Updated A(H1N1)pdm09 influenza virus ferret infection model permits refined antiviral assessment using aerosol inhalation challenge
DOI: 10.1371/journal.ppat.10146042026
Journal article
Pre-existing systemic and nasal antibodies against avian H5 influenza A viruses vary according to childhood imprinting.
DOI: 10.1128/mbio.01892-262026
Journal article
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2025
DOI: 10.33321/cdi.2026.50.0542026
Journal article
Immunogenicity of high-dose recombinant influenza vaccine versus standard-dose egg-grown and cell-grown vaccines among frequently and infrequently vaccinated young adults in Singapore: a randomised, controlled, double-blind, single-centre, phase 4 clinical trial
DOI: 10.1016/S1473-3099(26)00062-9
RECENT PROJECTS
2023
Research contracts (non-grants)
LEX45063: Development of a Bioluminescence Imager for Ferret